4//SEC Filing
Celanese CORP 4
Accession 0000893750-06-000313
$CECIK 0001306830operating
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 5:02 PM ET
Size
21.2 KB
Accession
0000893750-06-000313
Insider Transaction Report
Form 4
Transactions
- Sale
Series A common stock, par value $0.0001 per share
2006-11-13$20.10/sh−1,194,445$24,008,345→ 960,647 total(indirect: See footnotes) - Sale
Series A common stock, par value $0.0001 per share
2006-11-13$20.10/sh−17,222,715$346,176,572→ 13,851,589 total(indirect: See footnotes) - Sale
Series A common stock, par value $0.0001 per share
2006-11-13$20.10/sh−9,363,905$188,214,491→ 7,531,041 total(indirect: See footnotes)
Transactions
- Sale
Series A common stock, par value $0.0001 per share
2006-11-13$20.10/sh−17,222,715$346,176,572→ 13,851,589 total(indirect: See footnotes) - Sale
Series A common stock, par value $0.0001 per share
2006-11-13$20.10/sh−1,194,445$24,008,345→ 960,647 total(indirect: See footnotes) - Sale
Series A common stock, par value $0.0001 per share
2006-11-13$20.10/sh−9,363,905$188,214,491→ 7,531,041 total(indirect: See footnotes)
Transactions
- Sale
Series A common stock, par value $0.0001 per share
2006-11-13$20.10/sh−17,222,715$346,176,572→ 13,851,589 total(indirect: See footnotes) - Sale
Series A common stock, par value $0.0001 per share
2006-11-13$20.10/sh−9,363,905$188,214,491→ 7,531,041 total(indirect: See footnotes) - Sale
Series A common stock, par value $0.0001 per share
2006-11-13$20.10/sh−1,194,445$24,008,345→ 960,647 total(indirect: See footnotes)
SCHWARZMAN STEPHEN A
10% Owner
Transactions
- Sale
Series A common stock, par value $0.0001 per share
2006-11-13$20.10/sh−17,222,715$346,176,572→ 13,851,589 total(indirect: See footnotes) - Sale
Series A common stock, par value $0.0001 per share
2006-11-13$20.10/sh−1,194,445$24,008,345→ 960,647 total(indirect: See footnotes) - Sale
Series A common stock, par value $0.0001 per share
2006-11-13$20.10/sh−9,363,905$188,214,491→ 7,531,041 total(indirect: See footnotes)
PETERSON PETER G
10% Owner
Transactions
- Sale
Series A common stock, par value $0.0001 per share
2006-11-13$20.10/sh−1,194,445$24,008,345→ 960,647 total(indirect: See footnotes) - Sale
Series A common stock, par value $0.0001 per share
2006-11-13$20.10/sh−9,363,905$188,214,491→ 7,531,041 total(indirect: See footnotes) - Sale
Series A common stock, par value $0.0001 per share
2006-11-13$20.10/sh−17,222,715$346,176,572→ 13,851,589 total(indirect: See footnotes)
Transactions
- Sale
Series A common stock, par value $0.0001 per share
2006-11-13$20.10/sh−17,222,715$346,176,572→ 13,851,589 total(indirect: See footnotes) - Sale
Series A common stock, par value $0.0001 per share
2006-11-13$20.10/sh−9,363,905$188,214,491→ 7,531,041 total(indirect: See footnotes) - Sale
Series A common stock, par value $0.0001 per share
2006-11-13$20.10/sh−1,194,445$24,008,345→ 960,647 total(indirect: See footnotes)
Footnotes (6)
- [F1]Blackstone Capital Partners (Cayman) Ltd. 1 ("Cayman 1"), Blackstone Capital Partners (Cayman) Ltd. 2 ("Cayman 2") and Blackstone Capital Partners (Cayman) Ltd. 3 ("Cayman 3") and, collectively with Cayman 1 and Cayman 2, the "Cayman Entities"), respectively own 13,851,589, 960,647 and 7,531,041 shares of the Series A common stock reported as beneficially owned in the above table. Blackstone Capital Partners (Cayman) IV L.P. ("BCP IV") owns 100% of Cayman 1, Blackstone Family Investment Partnership (Cayman) IV-A L.P. ("BFIP") and Blackstone Capital Partners (Cayman) IV-A L.P. ("BCP IV-A") collectively own 100% of Cayman 2. Blackstone Chemical Coinvest Partners (Cayman) L.P. ("BCCP" and, collectively with BCP IV, BFIP and BCP IV-A, the "Blackstone Funds") owns 100% of Cayman 3.
- [F2]Each of the Blackstone Funds may be deemed to be the beneficial owner of the shares of Series A common stock held by the Cayman Entities owned by such Blackstone Funds. Blackstone Management Associates (Cayman) IV L.P. ("BMA") is the general partner of each of the Blackstone Funds and, therefore, may be deemed to be the beneficial owner of the shares of Series A common stock held by the Cayman Entities. Blackstone LR Associates (Cayman) IV Ltd. ("BLRA") is the general partner of BMA and may, therefore, be deemed to be the beneficial owner of the shares of Series A common stock held by the Cayman Entities.
- [F3]Messrs. Peter G. Peterson and Stephen A, Schwarzman are directors and controlling persons of BLRA and, as such, may be deemed to share beneficial ownership of the shares of Series A common stock held by the Cayman Entities.
- [F4]Due to the electronic system's limitation of 10 Reporting Persons per joint filing, this statement is being filed in duplicate.
- [F5]Information with respect to each of the Reporting Persons is given solely by such Reporting Persons, and no Reporting Person has responsibility for the accuracy or completeness of information supplied by another Reporting Person.
- [F6]Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of the Reporting Persons, other than the Cayman Entities, herein states that this filing shall not be deemed an admission that he or it is the beneficial owner of any of the shares of Series A common stock covered by this Statement. Each of BLRA, BMA, Messrs. Peter G. Peterson and Stephen A. Schwarzman disclaims beneficial ownership of the Series A common stock, except to the extent of its or his pecuniary interest in such shares of Series A common stock.
Documents
Issuer
Celanese CORP
CIK 0001306830
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001306830
Filing Metadata
- Form type
- 4
- Filed
- Nov 12, 7:00 PM ET
- Accepted
- Nov 13, 5:02 PM ET
- Size
- 21.2 KB